Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Several Indian Pharma companies get USFDA nod for Epilepsy Drug

      Posted AtEquitybulls.com

      Several Indian Pharmaceutical companies like Glenmark Generics Inc (a subsidiary of Glenmark Pharmaceuticas Limited), Orchid Chemicals & Pharmaceuticals Ltd, Aurobindo Pharma Ltd and Lupin Ltd has received the approval from US Food and Drug Administration for Levtiracetam tablets.

      Levetiracetam tablets are indicated as an adjunctive therapy for the treatment of partial onset Seizures in adults and children with Epilepsy.

      *According to IMS Health data for the 12 month period ending September 2008, Levetiracetam tablets recorded sales of USD 1.1 Billion, growing at a rate of 36% over the corresponding period for the previous year. For the 12 month period ending September 2008, Levetiracetam is ranked within the top 5 oral solid anti-epileptic (N3A) products.

      January 29, 2009


       

      Share this Article!

    Back to top^